Multispectral optoacoustic tomography for imaging muscles in centronuclear myopathy
Multispectral Optoacoustic Tomography for Advanced Imaging of Centronuclear Myopathy
This uses a painless MSOT scanning method to try to image muscles in people with centronuclear myopathy and in matched healthy volunteers for comparison.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 40 (estimated) |
| Ages | 2 Years and up |
| Sex | All |
| Sponsor | University of Erlangen-Nürnberg Medical School Academic / other |
| Drugs / interventions | radiation |
| Locations | 1 site (Erlangen, Bavaria) |
| Trial ID | NCT07021820 on ClinicalTrials.gov |
What this trial studies
This observational project will enroll 20 patients with centronuclear myopathy and 20 age- and sex-matched healthy controls. Participants undergo a physical exam, clinical and functional testing, and multispectral optoacoustic tomography (MSOT) scans at predefined muscle sites (paraspinal, trapezius, deltoid, forearm flexors, quadriceps, adductors, ischiocrural muscles, triceps surae, and tibialis anterior). The protocol is noninvasive and excludes children under 2 years, pregnant or nursing women, people with tattoos in the scan area, or those with more than 3 cm of subcutaneous fat at the scan site. Imaging and clinical data will be compared between groups to identify MSOT features associated with centronuclear myopathy.
Who should consider this trial
Good fit: People aged 2 years and older with a confirmed diagnosis of centronuclear myopathy who can attend the Erlangen site and meet the scan safety criteria are ideal candidates.
Not a fit: Those who are pregnant or nursing, have tattoos over the examination area, have more than 3 cm of subcutaneous fat at the scan site, or healthy volunteers should not expect direct clinical benefit from participation.
Why it matters
Potential benefit: If successful, this could provide a noninvasive imaging method to better visualize muscle changes and help monitor disease progression or response to future treatments.
How similar studies have performed: MSOT has shown promise in other muscle and vascular imaging research, but its specific application to centronuclear myopathy is novel and limited in published data.
Eligibility criteria
Show full inclusion / exclusion criteria
CNM arm: Inclusion Criteria: diagnosed CNM; minimum of 2 years of age Exclusion Criteria: * Pregnancy * Nursing mothers * Tattoo in the area of the examination field * Subcutaneous fatty tissue \> 3 cm HV: Inclusion criteria: minimum of 2 years of age Exclusion criteria: * any signs/history of muscle diseases * Pregnancy * Nursing mothers * Tattoo in the area of the examination field * Subcutaneous fatty tissue \> 3 cm
Where this trial is running
Erlangen, Bavaria
- Uniklinikum Erlangen — Erlangen, Bavaria, Germany (Recruiting)
Study contacts
- Study coordinator: Lina Tan
- Email: Lina.Tan@uk-erlangen.de
- Phone: +49 9131 85-41277
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.